A balance between apoptosis and proliferation of vascular smooth muscle cells (VSMC) influences the development of intimal hyperplasia. We have previously demonstrated that protein kinase C delta (PKCd) regulates both apoptosis and proliferation of VSMC in vitro. Here we investigate the role of PKCd in intimal hyperplasia through gene deletion or overexpression in rodent models of arterial injury.
Introduction
Intimal hyperplasia is an exaggerated healing response that occurs in the vessel wall after injury. It is a major cause of restenosis, which limits the success of many vascular interventions including bypass grafting, endarterectomy, and balloon angioplasty. 1 The development of neointimal hyperplasia is a complex process involving vascular inflammation, re-establishment of the luminal endothelial lining, progenitor cell recruitment, and smooth muscle cell (SMC) proliferation and apoptosis. 1, 2 It is thought that vascular SMCs undergo a behavioural change in response to injury, transforming from a quiescent and differentiated state to a proliferative and synthetic phenotype. 3 Another key characteristic of 'injured' SMCs is their resistance to apoptosis. SMCs, isolated from human endarterectomy lesions, were found to be insensitive to apoptotic stimuli. 4 As the number of SMCs accumulated in the intimal lesions is determined by the balance between cell proliferation and apoptosis, defining the molecular mechanisms underlying both proliferation and apoptosis is necessary in order to better understand the behavioural changes of SMCs after vascular injury and thus to develop novel therapeutic strategies to inhibit intimal hyperplasia. 5 Apoptosis is a multi-step process. In mammalian cells, apoptosis can be initiated through two main pathways. One pathway involves the activation of transmembrane death receptors such as Fas and TNF-a by their specific ligands leading to activation of caspase 8. The other pathway involves mitochondrial depolarization leading to the release of cytochrome c and activation of caspase 9. Both pathways ultimately result in activation of caspase 3, which then leads to apoptotic events including the cleavage of cell proteins, subsequent DNA fragmentation, and cell death. 6 Factors that activate death receptors or the mitochondriamediated apoptotic pathways are found to be abundant at the arterial wall of an injured artery.
Protein kinase C delta (PKCd) is a novel member of the PKC family, a major group of serine-threonine kinases. All PKC isotypes share a similar structure including an N-terminal regulatory domain and a C-terminal catalytic domain connected via a hinge region. We and others have previously demonstrated in cultured vascular SMCs (VSMCs) that PKCd is an important mediator of apoptosis in VSMCs. 7 -9 Inhibition of PKCd activity or expression diminishes activation of caspase cascade as well as its downstream death events including DNA fragmentation and externalization of phospholipids. 7, 9 Recently, our group showed that PKCd undergoes a caspase-3-mediated cleavage in the linker region to produce a catalytic fragment (CF) critical to the execution of cell death. 7 Results with PKCd knockout (KO) mice reveal that mice lacking PKCd develop normally and are fertile. When subjected to stress or injury, VSMCs of PKCd null mice showed an antiapoptotic phenotype. 8 In addition, PKCd null mice are found to exhibit enhanced proliferation of B cells and auto-immunity. 10 Using a mouse vein graft bypass model, Leitges and colleagues showed that PKCd null mice developed an exacerbated graft arteriosclerosis associated with diminished cell apoptosis, suggesting this kinase might be an integral element of vascular injury. 8 In cultured VSMCs, PKCd has been shown to negatively regulate proliferation. 11, 12 Overexpression of this kinase in VSMC leads to G1 cell cycle arrest 12 and impaired activation of mitogen-activated protein kinase extracellular signal-regulated kinase (ERK)1/2 11 . However, inhibition of PKCd either by gene deletion 11 or dominant negative mutant also affects ERK activation. 13 The precise relationship between PKCd and ERK remains to be further investigated.
One of the distinctive properties of both human atherosclerosis and restenosis is the locality of lesions, which is related to differences in local hemodynamics as well as the regional differences in vessel wall physiology. Different vascular interventions, namely bypass, endarterectomy, angioplasty, and stenting, produce different kinds of injuries to the vessel which could subsequently elicit distinct injury responses. Clinically, the incidence of intimal hyperplasia and restenosis during long-term follow up varies significantly among different vascular interventions. 14, 15 Therefore, it is important to study PKCd and its role in VSMC apoptosis and proliferation in multiple experimental models that mimic various vascular interventions.
In this report, we examined PKCd function in the arterial wall using two rodent arterial injury models. Through genetic or molecular manipulations, we tested the effect of PKCd inhibition or overexpression on VSMC apoptosis, proliferation, and intimal hyperplasia. These studies provide an explicit link between PKCd and the pathogenesis of intimal hyperplasia after arterial injury.
Methods

General materials
Dulbecco's modified Eagles medium (DMEM) and cell culture reagents were from Gibco BRL Life Technologies. Chemicals, if not specified, were purchased from Sigma Chemical Co.
Animal model
Male Sprague-Dawley rats weigh around 300 g underwent angioplasty of the left common carotid artery with or without viral perfusion as described elsewhere. 16 Construction of a PKCd and beta-galactosidase expressing recombinant adenoviral vector (Ad PKCd and Ad LacZ) and subsequent intraluminal delivery immediately after arterial injury were performed as previously described. 16, 17 The generation of PKC target deletion was described elsewhere.
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PKCd KO mouse and their wild-type (WT) littermates, around 12 weeks old, underwent ligation of left carotid artery injury as described previously. 18 The arteries were then harvested by perfusion fixation with 4% paraformaldehyde at a physiologic pressure of 100 mmHg. 
Cell culture
Rat carotid arterial smooth muscle cells (rat VSMCs), and mouse aortic VSMCs, from the thoracic aorta of both PKC KO, and WT mouse, were isolated based on a protocol described by Clowes et al. 19 The isolated cells were grown and maintained as recommended at 378C in 5% CO 2 in DMEM modified to contain 4 mM L-glutamine, 1.0 g/L glucose, 1 mM sodium pyruvate, 1.5 g/L sodium bicarbonate, supplemented with 10% foetal bovine serum (FBS; Gemini, Woodland, CA, USA), and antibiotics.
Human atherectomy specimens
Specimens were retrieved from the superficial femoral artery of patients undergoing atherectomy for restenotic lesions after stenting and/or prior angioplasty (n ¼ 3). All specimens were collected under the approval of the Institutional Review Board at Cornell University (# 9704001187). The investigation conforms with the principles outlined in the Declaration of Helsinki.
Morphometric analysis and immunohistochemistry
Paraffin embedded arteries were cut into 5 mm sections for analysis. Morphometric analysis was carried out on elastin-stained arteries. For rat balloon-injured artery, 10 sections were randomly selected. For mouse ligation injured artery, five transverse sections at 3 -4 mm proximal to the ligation site were obtained in each animal as described previously. 20 The areas encompassed by the lumen surface (luminal area), internal elastic lamina-lumen surface (intimal area), external elastic lamina (EEL)-internal elastic lamina (medial area), and EEL length were measured. For the evaluation of the degree of intimal hyperplasia, the ratio of intimal area to medial area (I/M ratio) was calculated and compared using digital imaging software (ImageJ 1.36b), as described previously.
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Protein kinase C delta inhibits arterial restenosis Immunohistochemistry using rabbit anti-PKCd 1:50 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was performed, and PKCd positive area in the media was calculated as described elsewhere. 21, 22 TUNEL staining was performed under manufacturer's instruction. Immunofluorescent staining was performed with mouse anti-Ki67 1:100 (AbCam), rabbit anti-PKCd 1:50 (Santa Cruz Biotechnology), rabbit anti-cleaved caspase-3 antibody (Cell signalling), and donkey anti-mouse Alexa 555 or donkey anti-rabbit Alexa 488 (Molecular Probes). TO-PRO 3 (Molecular Probes) was used to identify nuclei. Staining was visualized with a Nikon Eclipse E800 upright microscope and digital images were acquired using a RetigaEXi CCD digital camera. Fluorescent staining was visualized and digital images were taken on a Zeiss LSM 510 Laser Scanning Confocal imaging system with the appropriate argon beam lasers. For each specimen, cells were counted in four fields at 882Â magnification. Digital images were analysed using Zeiss Image Browser software. TUNEL and Ki67 Indices were calculated as (number of positive cells/number of total nuclei) per section by identifying positive cells vs. TO-PRO3 positive cells from at least eight independent fields from five sections in each sample using NIH image software (ImageJ 1.36b).
Immunoblot analysis
Arteries were removed from surrounding tissues and harvested under the surgical microscope. Harvested arteries were rinsed with PBS and homogenized as descried previously. 16, 23 For cellular studies, VSMCs were made quiescent by incubation in medium containing 0.5% FBS for 48 h. Cells were then treated with H 2 O 2 at various concentrations and times, and then lysed in 50 mM Tris -HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS and subjected to SDS-PAGE and transferred to a polyvinylidene difluoride (Bio-Rad, Hercules, CA, USA) membrane. Membranes were incubated with rabbit polyclonal antibodies to rabbit anti-PKCd (Santa Cruz Biotechnology), and mouse anti-b-actin (Sigma). Labelled proteins were visualized with an enhanced chemi-luminescence system (PerkinElmer Life Sciences, Boston, MA).
Apoptosis assay
DNA fragmentation was determined using the Cell Death Detection ELISA system (Roche Applied Science, Indianapolis, IN, USA), an assay based on a quantitative sandwich-enzyme-immunoassay principle using mouse monoclonal antibodies directed against DNA and histones. Cellular extracts were incubated in 96-well plates coated with anti-histone antibodies. Plates were then incubated with anti-DNA antibodies conjugated to peroxidase for 2 h, and absorbance was measured at 405 nm.
Statistical analysis
Values were expressed as fold increases (means + standard error) from at least three independent experiments unless stated otherwise. Differences between two groups were analysed by Student's t test, and one-way analysis of variance followed by Scheffe's test was used for multiple comparisons. Values of P , 0.05 were considered significant.
Results
Temporal expression of PKCd after balloon angioplasty
To elucidate the role of PKCd in vascular injury response, we first evaluated PKCd expression in rat carotid arteries harvested 3, 7, 14, and 28 days after balloon angioplasty. As compared with non-injured arteries, arteries at day 3 post-injury exhibited significantly higher immunostaining to PKCd. The PKCd expression was highest at day 7, and returned to baseline level at day 14 ( Figure 1A and B). To better quantify the injury-induced PKCd expression, we performed western blot analysis. Protein extract isolated from balloon-injured arteries showed a markedly higher level of PKCd than that from sham-operated arteries ( Figure 1C ). The CF of PKCd, known to be associated with PKCd mediated apoptosis, was abundantly present in injured arteries while it was barely detectable in sham-operated arteries ( Figure 1C) . To further explore the relationship between high PKCd expression and apoptosis in injured arteries, we double-stained arterial sections for PKCd and TUNEL. As shown in Figure 1D , the temporal and spatial patterns of the expression in PKCd were very similar to that of TUNEL staining ( Figure 1D -E) . Immunostaining for cleaved caspase-3 also showed similar pattern as TUNEL staining ( Figure 1F ).
The role of PKCd in VSMC apoptosis in vitro
To mimic the high expression we observed in the arterial wall following balloon injury, we forced higher PKCd expression in normal VSMCs using an adenoviral vector carrying the full-length PKCd cDNA (Ad PKCd). As shown in Figure 2A , normal, un-manipulated aortic VSMCs responded to H 2 O 2 with an induction of apoptosis in a dose-dependent manner as measured by ELISA for DNA fragmentation. Western blotting indicated that H 2 O 2 treatment elicited the formation of the pro-apoptotic CF, which was undetectable in control cells ( Figure 2B ). The level of full-length PKCd was slightly higher in H 2 O 2 -treated cells, however this increase was not statistically significant (fold induction: 1.28 + 0.12, n ¼ 4, P ¼ 0.14) ( Figure 2B ). Infection of aortic VSMCs with a control adenovirus (Ad LacZ) did not change the apoptotic responses of these cells to H 2 O 2 . In contrast, infection of VSMCs with Ad PKCd markedly increased their apoptotic responses, including elevated DNA fragmentation and formation of CF ( Figure 2C) . Conversely, inhibition of PKCd activity by targeted gene deletion completely eliminated not only the expression of PKCd but the ability to undergo apoptosis when stimulated with H 2 O 2 ( Figure 2E and F ).
Accelerated intimal hyperplasia in PKCd KO mouse
We speculated that the lack of apoptotic response in PKCd null mice might elicit an accelerated incidence of neointimal formation after arterial injury. To test this hypothesis, we generated arterial injury by ligating the carotid artery of PKCd WT or KO mouse. Twenty-eight days after ligation, arteries were harvested for morphological analysis. As compared with the WT controls, the injured arteries of PKCd KO mice showed a significant increase in neointimal formation, reflected by an increase of over 65% in intimal to media ratio (I/M ratio) ( Figure 3A -C) . Accordingly, the luminal area of the PKCd null arteries was reduced by 50% ( Figure 3D ). However, there is no significant difference in the length of EEL, a parameter for arterial remodelling ( Figure 3E ).
Cell apoptosis in PKCd KO mouse after carotid ligation
Next we compared the degree of apoptosis between PKCd KO and WT littermates after ligation injury. The carotid arteries of PKCd KO and WT were subjected to carotid ligation, and were harvested after 3 or 14 days. As shown in Figure 3F and G, apoptosis was attenuated in PKCd KO arteries at both 3 and 14 days. In contrast, PKCd gene deletion did not lead to any significant alteration in arterial cell proliferation as measured by immunostaining for the proliferation marker Ki67 ( Figure 3F and H ).
PKCd gene transfer following arterial injury
Next, we extended our in vitro PKCd gene transfer study to an arterial injury model. Here, we used a rat carotid balloon injury Protein kinase C delta inhibits arterial restenosis because luminal gene transfer cannot be flawlessly accomplished in mice due to their small arterial size. Immediately following balloon angioplasty, the injured arteries were infected with Ad PKCd or Ad LacZ. The arteries were harvested after 14 days for morphological analyses. As shown in Figure 4 , Ad PKCd infection significantly reduced the neointimal formation, reflected by a 30% reduction in I/M ratio in comparison with Ad LacZ infected arteries. In addition, Ad PKCd increased luminal area by 30% without significantly changing EEL length ( Figure 4D ).
Apoptosis after balloon injury in the presence of PKCd overexpression
To test whether Ad PKCd inhibits neointimal formation by stimulating apoptosis of arterial VSMC, we evaluated PKCd expression, cell apoptosis, and proliferation in the carotid arteries after balloon injury/gene transferring. Immunostaining for PKCd confirmed the success of gene transfer, indicated by the elevated PKCd at both days 3 and 7 as compared with Ad LacZ infected arteries ( Figure 5A ). TUNEL analysis showed extensive upregulation of apoptosis in Ad PKCd-infected arteries ( Figure 5A and B). At day 3, the percentage of TUNEL-positive cells in the tonic media was 21% in Ad PKCd infected arteries as compared with 6% of Ad LacZ-infected arteries. The upregulation of apoptosis persisted to day 7 in both media and intima, then subsided at 14 days ( Figure 5A and B) . In contrast, immunostaining for Ki67 showed no significant difference in proliferation between Ad PKCd and Ad LacZ-infected arteries at all time points ( Figure 5C ). Since the intima at day 3 was undetectable, we have presented both TUNEL and Ki67 index in the intima only at days 7 and 14. Protein kinase C delta inhibits arterial restenosis
PKCd expression and apoptosis in human restenotic artery
To determine whether PKCd expression is altered in restenotic arteries, samples were collected from the superficial femoral artery of patients who underwent atherectomy for restenotic lesions. Immunohistochemical analysis for PKCd showed robust expression of PKCd in restenotic lesions ( Figure 6 ). The double staining for PKCd and TUNEL revealed co-localization of PKCd and TUNEL-positive cells ( Figure 6C -F ) .
Discussion
Arterial responses to injury involve many molecular changes, including the upregulation of cytokines, growth factors, and certain matrix proteins. 24 -26 Here, we have reported a novel molecular alteration following arterial injury. The injury-induced elevation in PKCd protein expression was profound and acute. By day 3 following balloon angioplasty of a rat carotid artery, the protein level of PKCd was increased significantly evidenced by both immunohistological and biochemical analyses. The induction of the CF of PKCd was even more dramatic. Of note, the tumour suppressor p53, a pro-apoptotic factor that we have previously shown to be regulated by PKCd, was previously reported to be upregulated 7 days after injury.
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The co-localization of PKCd with apoptotic cells extended to human restenotic lesions (as seen in this study) as well as aortic specimens of aneurysm patients, 28 ing of the rat carotid arteries infected with adenovirus encoding PKCd (Ad PKCd) or beta-galactosidase (Ad LacZ). Arteries were harvested and analysed at the indicated time points post-injury. For double staining of PKCd and TUNEL (left panels), the cross-sections were stained for nuclei (blue), TUNEL (red), and PKCd (green). For Ki67 staining (right panels), the sections were stained for nuclei (blue) and Ki67 (green). Merged images are shown on the right panels (scale bar¼100 mm). TUNEL index (B) and Ki67 index (C) were calculated as a percentage of the number of positive cells to the number of total cells in the balloon-injured arteries infected with Ad PKCd or Ad LacZ (n ¼ 6, *P , 0.05 as compared with Ad LacZ-infected arteries).
Protein kinase C delta inhibits arterial restenosis However, neither PKCd gene deficiency nor adenovirus-mediated gene transfer led to significant alterations in the number of proliferating cells after arterial injury in both ligation and angioplasty models. Accordingly, no significant change in cell proliferation was also reported in PKCd KO mice when subjected to vein bypass. 8 The lack of effect on vascular proliferation by PKCd suggests that the dominant role of this kinase in an injured artery is to regulate cell apoptosis rather than proliferation. PKCd can be activated by many extracellular factors including mechanical stress, pro-inflammatory cytokines, and oxidative stress, all of which are known to be associated with arterial injury. 7, 26, 30 Mechanisms regarding how PKCd is activated by various stimuli include binding of second messenger diacylglycerol, phosphorylation, membrane translocation, and proteolysis. Recently, we used a rat aortic VSMC line to show that the caspase-3-mediated cleavage of PKCd is a necessary step in the apoptotic pathway leading to execution of death events elicited by H 2 O 2 . 7 In the present study, we detected the CF, the product of PKCd cleavage, in the tissue extract of injury carotid arteries but not in uninjured arteries. This finding indicates that a similar activation mechanism of PKCd exists in the arterial wall, perhaps responding to increased oxidative stress associated with arterial injury.
We are tempted to postulate that alterations in intimal hyperplasia produced by PKCd KO or gene expression are primarily mediated by the pro-apoptotic function of this kinase. However, our study does not rule out potential effects of PKCd on other players of intimal hyperplasia. Compared with the extensive degree of apoptosis induced by PKCd overexpression, the suppressive effect of PKCd overexpression on intimal hyperplasia was not as profound as we had anticipated. We performed a preliminary evaluation of inflammation in the overexpression model revealing no significant presence of CD69þ macrophages in injured carotid wall in either the presence or absence of Ad PKCd. In order to completely rule out any potential effect of PKCd on inflammatory response after arterial injury, markers for other inflammatory cells need to be evaluated. Alternatively, PKCd could affect the recruitment of bone marrow derived progenitor cells to the injured artery. In a separate study, we found that VSMCs can attract progenitor cells by secreting monocyte chemoattracting protein-1 (MCP-1). 16 The vital role of MCP-1 in the pathogenesis of arterial remodelling has been previously reported. 31 In vitro, we have found that PKCd is a major mediator of MCP-1 expression by VSMCs. 28 If this stimulatory function of PKCd regarding to MCP-1 expression is proven to exist during arterial injury, the beneficial effect of PKCd in the promotion of VSMC apoptosis may be offset by its coincident stimulation of MCP-1, thus recruitment of progenitor cells. A reliable bone marrow transplant model is necessary in order to test this hypothesis following rat carotid balloon injury. In summary, we showed upregulation of PKCd accompanied by apoptosis of VSMC in the arterial wall in response to injury. Through alterations of PKCd expression in rodent artery injury models, we demonstrated the suppressive effect of PKCd on the development of intimal hyperplasia after arterial injury, primarily through the stimulation of VSMC apoptosis.
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